Citigroup Inc Infinity Pharmaceuticals, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.46 - $1.21 $505 - $1,329	-1,099 Reduced 91.13%	107 $0
Q3 2022 Nov 10, 2022	SELL	$0.59 - $1.7 $1,778 - $5,125	-3,015 Reduced 71.43%	1,206 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.49 - $1.2 $456 - $1,117	-931 Reduced 18.07%	4,221 $3,000
Q1 2022 May 12, 2022	SELL	$0.85 - $2.4 $16,677 - $47,090	-19,621 Reduced 79.2%	5,152 $6,000
Q4 2021 Feb 10, 2022	BUY	$1.86 - $3.36 $27,342 - $49,392	14,700 Added 145.93%	24,773 $56,000
Q3 2021 Nov 10, 2021	BUY	$1.52 - $3.82 $15,310 - $38,478	10,073 New	10,073 $34,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.